chrX-40052319-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001123385.2(BCOR):c.5058C>T(p.Asn1686=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000686 in 1,210,138 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000062 ( 0 hom. 34 hem. )
Consequence
BCOR
NM_001123385.2 synonymous
NM_001123385.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0270
Genes affected
BCOR (HGNC:20893): (BCL6 corepressor) The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant X-40052319-G-A is Benign according to our data. Variant chrX-40052319-G-A is described in ClinVar as [Benign]. Clinvar id is 1581317.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-40052319-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.027 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 34 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BCOR | NM_001123385.2 | c.5058C>T | p.Asn1686= | synonymous_variant | 15/15 | ENST00000378444.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BCOR | ENST00000378444.9 | c.5058C>T | p.Asn1686= | synonymous_variant | 15/15 | 1 | NM_001123385.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 15AN: 112385Hom.: 0 Cov.: 23 AF XY: 0.0000289 AC XY: 1AN XY: 34549
GnomAD3 genomes
AF:
AC:
15
AN:
112385
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34549
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000818 AC: 15AN: 183452Hom.: 0 AF XY: 0.000118 AC XY: 8AN XY: 67908
GnomAD3 exomes
AF:
AC:
15
AN:
183452
Hom.:
AF XY:
AC XY:
8
AN XY:
67908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000619 AC: 68AN: 1097702Hom.: 0 Cov.: 30 AF XY: 0.0000936 AC XY: 34AN XY: 363062
GnomAD4 exome
AF:
AC:
68
AN:
1097702
Hom.:
Cov.:
30
AF XY:
AC XY:
34
AN XY:
363062
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000133 AC: 15AN: 112436Hom.: 0 Cov.: 23 AF XY: 0.0000289 AC XY: 1AN XY: 34610
GnomAD4 genome
AF:
AC:
15
AN:
112436
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34610
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Oculofaciocardiodental syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 03, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at